Pharmaceutical Representatives' Opinion about Pharmacists' Drug Dispensing Practices in Romania and Factors that Influence them

Laszlo-Zoltan Sztankovszky¹, Magdalena Iorga^1, and Vasile Astaratoae¹

¹Behavioral Sciences, Department of Preventive Medicine and Interdisciplinarity, University of Medicine and Pharmacy “Gr.T.Popa” Iasi, Romania

Cite this paper

Laszlo-Zoltan Sztankovszky, Magdalena Iorga and Vasile Astaratoae. Pharmaceutical Representatives' Opinion about Pharmacists' Drug Dispensing Practices in Romania and Factors that Influence them. American Journal of Public Health Research. 2016; 4(3):88-92. doi: 10.12691/AJPHR-4-3-2

Abstract

The objective of the research is to identify pharmaceutical representatives’ opinions on some practices of drug dispensing amongst community pharmacists in Romania. Material and methods: 70 pharmaceutical representatives working with different pharmaceutical companies in Romania answered questions regarding practices of drug dispensing. Different variables were taken into account: age, gender, type of education, and length of employment time. Collected data were analyzed with SPSS 17.0. Results: over 70% of the pharmaceutical representatives consider that pharmacists counsel the patient regarding other drug brand names and take into consideration patient financial contribution when dispensing a certain drug. Regarding the relationship of the pharmacist with doctor and rep, 65% of pharmaceutical representatives consider the relationship with the doctor, and 40% the relationship with the rep, important when dispensing a drug. No important differences were identified in relation to the gender or type of education. Conclusion: the study provides information regarding pharmaceutical representatives’ opinions on practices of drug dispensing. More than 2/3 of the reps consider that pharmacists are counseling the patient regarding a drug to a high level.

Keywords

pharmaceutical representative, drug dispensing, pharmacist, practices

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Hirsh, H., Coen, M.H., Mozer, M.C., Hasha, R. and Flanagan, J.L, “Room service, AI-style,” IEEE intelligent systems, 14 (2). 8-19. Jul.2002.
[2]	Barcaccia, B., Esposito, G., Matarese, M., Bertolaso, M., Elvira, M., De Marinis, M. G. “Defining quality of life: a wild-goose chase?” Europe’s Journal of Psychology, 9(1). 185-203. 2013.
[3]	Bielderman, A., de Greef, M. H. G., Krijnen, W. P., van der Schans, C. P. “Relationship between socioeconomic status and quality of life in older adults: a path analysis,”Quality of Life Research, 1-9. 2014.
[4]	Avorn, J. Solomon, D. H. “Cultural and economic factors that (mis) shape antibiotic use: the nonpharmacologic basis of therapeutics,” Annals of Internal Medicine, 133(2). 128-135. 2000.
[5]	McKinlay, J. B., Trachtenberg, F., Marceau, L. D., Katz, J. N., Fischer, M. A. “Effects of patient medication requests on physician prescribing behavior: results of a factorial experiment,” Medical care, 52(4). 294-299. 2014.
[6]	Ostini, R., Hegney, D., Jackson, C. &Tett, S. E. “Knowing how to stop: ceasing prescribing when the medicine is no longer required,” J Manag Care Pharm, 18(1). 68-72. 2012.
[7]	Kaiser, B., Schmid, C. “Does physician dispensing increase drug expenditures? Empirical evidence from Switzerland. Health economics,” 2014.
[8]	Fox, N. J., Ward, K. J., O’Rourke, A. J. “The ‘expert patient’: empowerment or medical dominance? The case of weight loss, pharmaceutical drugs and the Internet,” Social Science & Medicine, 60(6). 1299-1309. 2005.
[9]	Lorig, K. “Partnerships between expert patients and physicians,” The Lancet, 359(9309). 814-815. 2002.
[10]	Shaw, J, Baker, M. “Expert patient — dream or nightmare? The concept of a well informed patient is welcome, but a new name is needed,” BMJ: British Medical Journal, 328(7442). 723-724. 2004.
[11]	Kisa, A. The Performance and Problems of the Turkish Pharmaceutical Industry: Is there a need to develop a national drug policy? Journal of medical system 2001; 25:5:309-318.
[12]	Wang, D., Thumula, V., Liu, T. C. “”Are physician dispensing reforms sustainable?” http://www.wial.com/documents/2015/04/wcri-paper-2.pdf Retrieved at 10 June 2015.
[13]	Hussain, A., & Ibrahim, M. I. M. “Medication counselling and dispensing practices at community pharmacies: A comparative cross sectional study from Pakistan,” International journal of clinical pharmacy, 33(5). 859-867. 2011.
[14]	Dueñas, G. G., Pringle, J. L. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. Journal of American Pharmacists Association 2010; 50:67-71.
[15]	Muijrers, P. E., Grol, R. P., Sijbrandij, J., Janknegt, R. &Knottnerus, J. A. Differences in prescribing between GPs. Impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives. Family Practice 2005; 22:6:624-630.
[16]	Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G., Epstein, A. M. “Promotion of prescription drugs to consumers,” New England Journal of Medicine, 346(7). 498-505. 2002.
[17]	Sztankovszky, L.Z., Soponaru, C., Iorga, M., Astarastoae, V. “Pharmacists' and doctors’ perception of pharmaceutical representative’s ethical practices of drug promotion in Romania. A comparative study,” Postmodern Openings; 6(1). 189-199. 2015.
[18]	Beatty, S. J., McCormick, K. M., Beale, D. J., Bruggeman, A. M., Rodis, J. L., Mehta, B. H., Bennett, M. S. “Current trends in outpatient pharmacy services and billing,” Journal of the American Pharmacists Association,52(2). 154-160. 2012.
[19]	Doucette, W. R., McDonough, R. P., Mormann, M. M., Vaschevici, R., Urmie, J. M., Patterson, B. J. “Three-year financial analysis of pharmacy services at an independent community pharmacy,” Journal of the American Pharmacists Association, 52(2). 181-187. 2012.
[20]	Lopez-Trigo, P., Khanfar, N. M., Alameddine, S., Harrington, C. “Banning Tobacco Sales at the Retail Pharmacy: Natural Evolution of Drug Store as Responsible Health Provider Or Effective Marketing Strategy?” Health marketing quarterly, 382-393. 2015.
[21]	Harding, G., Taylor, K. M. G. “Pharmacy's strength lies in its blend of clinical, scientific and social skills,” Pharmaceutical Journal, 273. 126. 2004.
[22]	Iorga, M., Sztankovszky, L.Z., Soponaru, C., Gardikiotis, I. “Pharmacists’s attitudes and practices regarding drug dispensing in Romania,” Revista Farmacia, 63(4). 601-606. 2015.
[23]	Sztankovszky, L. Z., Iorga, M., Diaconescu, S., Astarastoae, V. “Is the Family Doctors' drug Prescribing Behavior Influenced by the Relationship with Pharmacists and Pharmaceutical Representatives?”, Social Research Reports, 27. 88-95. 2015.